LEADER 01548nam  2200385Ia 450 
001 9910698993603321
005 20090610162550.0
035   $a(CKB)5470000002397935
035   $a(OCoLC)385030725
035   $a(EXLCZ)995470000002397935
100   $a20090610d2008      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for the public, FDA advisory committee members, and FDA staff$b[electronic resource] $epublic availability of advisory committee members' financial interest information and waivers
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration,$d[2008]
215   $a14 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on June 10, 2009).
300   $a"August 2008".
517   $aGuidance for the public, FDA advisory committee members, and FDA staff 
606   $aWaiver$zUnited States
606   $aFinancial disclosure$xGovernment policy$zUnited States
606   $aPublic health advisory groups$xGovernment policy$zUnited States
615  0$aWaiver
615  0$aFinancial disclosure$xGovernment policy
615  0$aPublic health advisory groups$xGovernment policy
712 02$aUnited States.$bFood and Drug Administration.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698993603321
996   $aGuidance for the public, FDA advisory committee members, and FDA staff$93493037
997   $aUNINA